Meeting Information:ORoC will hold a web-based meeting to obtain information related to evaluating human epidemiologic studies on exposure to pentachlorophenol and cancer risk, especially for lymphoma and multiple myeloma. In planning for this event, ORoC is inviting the nomination of speakers who would make presentations that focus on the methods used in human epidemiologic studies of pentachlorophenol to evaluate potential confounding from occupational co-exposures, other types of information that may be important in evaluating potential confounding, and how exposure to confounders may affect each study's findings. Once plans for the web-based meeting are finalized, additional information including agenda, speakers, logistics, and registration, will be announced in a subsequentFederal Registernotice.
Request for Nominations of Speakers:ORoC invites the nomination of speakers for the web-based meeting with expertise in epidemiology and knowledge of cancer studies on exposure to pentachlorophenol. Self-nomination is permitted. Each nomination should include (1) Contact information for the nominee [name,affiliation (if any), address, telephone, fax, and email], (2) a short description of the individual's expertise relative to the review of human epidemiologic studies of exposure to pentachlorophenol and cancer risk, (3) curriculum vitae, and (4) an abstract describing what would be covered in the talk to address the presentations' focus as noted above in “Meeting Information.” Persons submitting nominations should provide their name, contact information, affiliation, and sponsoring organization (if any). Nominations should be submitted to Dr. Lunn (seeADDRESSES); their receipt will be acknowledged by email. The deadline for nominations is December 3, 2012. Persons selected as speakers will be notified by email at least 30 days prior to the meeting.
Background Information on the RoC:The RoC is a congressionally mandated document that identifies and discusses substances that may pose a hazard to human health by virtue of their carcinogenicity. Substances are listed in the report as either known or reasonably anticipated human carcinogens. The NTP prepares the RoC on behalf of the Secretary of Health and Human Services following a formal, multi-step process for review and evaluation of selected substances (http://ntp.niehs.nih.gov/go/rocprocess). Information about the RoC is available on the RoC Web site (http://ntp.niehs.nih.gov/go/roc) or by contacting Dr. Lunn (seeADDRESSES).
Dated: October 11, 2012.
John R. Bucher,
Associate Director, National Toxicology Program.